Close Menu
NEW YORK – Genomica, a Spanish molecular diagnostics firm owned by the PharmaMar Group, has obtained CE marking for its COVID-19 (SARS-CoV2) coronavirus diagnostic kits.
 
The company has developed two kits: qCOVID-19, which uses real-time PCR, and CLART COVID-19, which uses the company's CLART technology, a low-density microarray-based platform that allows the detection of multiple targets in a single test.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.